Skip to main content

Table 3 Haemoglobin concentration and anaemia among women enrolled in Burkina-Faso and Mali

From: Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study

Characteristics

Burkina-Faso

Mali

All

Day 0

   

N

311

246

557

Mean haemoglobin (SD), g/dl

10.1 (1.4)

9.6 (1.6)

9.9 (1.5)

Anaemia (<11 g/dl), n (%)

225 (72.4)

198 (80.5)

423 (75.9)

Day 14

   

N

301

237

538

Mean haemoglobin (SD), g/dl

10.2 (1.3)

10.1 (1.4)

10.2 (1.3)

Anaemia (<11 g/dl), n (%)

208 (69.1)

177 (74.7)

385 (71.6)

Mean difference, 95% CIa

0.13 (0.004, 0.26)

0.44 (0.28, 0.59)

0.26 (0.16, 0.36)

Risk ratio, 95% CIb

0.96 (0.86, 1.06)

0.93 (0.84, 1.02)

0.94 (0.88, 1.01)

Day 28

   

N

290

244

534

Mean haemoglobin (SD), g/dl

10.7 (1.2)

10.6 (1.2)

10.6 (1.2)

Anaemia (<11 g/dl), n (%)

171 (59.0)

153 (62.7)

325 (60.7)

Mean difference, 95% CIa

0.60 (0.46,0.74)

0.87 (0.69, 1.06)

0.72 (0.61, 0.83)

Risk ratio, 95% CIb

0.82 (0.72, 0.92)

0.78 (0.70, 0.87)

0.80 (0.74, 0.87

Day 42

   

N

265

249

514

Mean haemoglobin (SD), g/dl

11.0 (1.2)

10.9 (1.3)

10.9 (1.3)

Anaemia (<11g/dl), n (%)

127 (47.9)

120 (48.2)

247 (48.1)

Mean difference, 95% CIa

0.87 (0.65, 1.09)

1.30 (1.11, 1.49)

1.06 (0.93, 1.18)

Risk ratio, 95% CIb

0.66 (0.57, 0.77)

0.60 (0.52, 0.69)

0.63 (0.57, 0.70)

  1. Notes:
  2. N, sample size; n, number of events; SD, standard deviation; g/dl, gram per decilitre; CI, confidence interval.
  3. aMean difference and 95% confidence interval for each time that haemoglobin was measured using day 0 as reference category.
  4. bRisk ratio and 95% confidence interval for each time that haemoglobin was measured using day 0 as reference category, adjusted for gravida and site (all), and for gravida (in each country).